AKBM Fundamental Analysis - AKER BIOMARINE ASA

Fundamental Rating

AKBM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 58 industry peers in the Food Products industry. Both the profitability and the financial health of AKBM get a neutral evaluation. Nothing too spectacular is happening here. AKBM has a decent growth rate and is not valued too expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AKBM was profitable.

AKBM had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: AKBM reported negative net income in multiple years.

AKBM had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With an excellent Return On Assets value of 48.54%, AKBM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

Looking at the Return On Equity, with a value of 110.84%, AKBM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	48.54%
ROE	110.84%
ROIC	N/A

ROA(3y)15.56%

ROA(5y)8.97%

ROE(3y)34.62%

ROE(5y)20.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 93.94%, AKBM belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

AKBM has a Gross Margin (34.97%) which is comparable to the rest of the industry.

In the last couple of years the Gross Margin of AKBM has declined.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	93.94%
GM	34.97%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.1%

GM growth 5Y-2.15%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AKBM does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for AKBM remains at a similar level compared to 1 year ago.

The number of shares outstanding for AKBM remains at a similar level compared to 5 years ago.

The debt/assets ratio for AKBM has been reduced compared to a year ago.

2.2 Solvency

A Debt/Equity ratio of 0.89 indicates that AKBM is somewhat dependend on debt financing.

AKBM's Debt to Equity ratio of 0.89 is on the low side compared to the rest of the industry. AKBM is outperformed by 70.69% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.89
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACC8.56%

2.3 Liquidity

AKBM has a Current Ratio of 3.47. This indicates that AKBM is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 3.47, AKBM belongs to the top of the industry, outperforming 89.66% of the companies in the same industry.

AKBM has a Quick Ratio of 1.81. This is a normal value and indicates that AKBM is financially healthy and should not expect problems in meeting its short term obligations.

AKBM has a better Quick ratio (1.81) than 84.48% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.47
Quick Ratio	1.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 5151.99% over the past year.

AKBM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -41.57%.

The Revenue has been decreasing by -4.17% on average over the past years.

EPS 1Y (TTM)5151.99%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%83.2%

Revenue 1Y (TTM)-41.57%

Revenue growth 3Y-8.77%

Revenue growth 5Y-4.17%

Sales Q2Q%-35.12%

3.2 Future

Based on estimates for the next years, AKBM will show a very strong growth in Earnings Per Share. The EPS will grow by 108.01% on average per year.

The Revenue is expected to grow by 20.59% on average over the next years. This is a very strong growth

EPS Next Y80%

EPS Next 2Y123.61%

EPS Next 3Y108.01%

EPS Next 5YN/A

Revenue Next Year-13.85%

Revenue Next 2Y-1.34%

Revenue Next 3Y3.16%

Revenue Next 5Y20.59%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

AKBM is valuated cheaply with a Price/Earnings ratio of 2.76.

AKBM's Price/Earnings ratio is rather cheap when compared to the industry. AKBM is cheaper than 96.55% of the companies in the same industry.

When comparing the Price/Earnings ratio of AKBM to the average of the S&P500 Index (27.15), we can say AKBM is valued rather cheaply.

With a Price/Forward Earnings ratio of 23.32, AKBM is valued on the expensive side.

Based on the Price/Forward Earnings ratio, AKBM is valued a bit more expensive than 68.97% of the companies in the same industry.

The average S&P500 Price/Forward Earnings ratio is at 21.60. AKBM is around the same levels.

		Industry Rank	Sector Rank
PE	2.76
Fwd PE	23.32

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKBM indicates a slightly more expensive valuation: AKBM is more expensive than 77.59% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	20.91

4.3 Compensation for Growth

AKBM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

AKBM's earnings are expected to grow with 108.01% in the coming years. This may justify a more expensive valuation.

PEG (NY)0.03

PEG (5Y)N/A

EPS Next 2Y123.61%

EPS Next 3Y108.01%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AKBM does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AKER BIOMARINE ASA

OSL:AKBM (7/1/2025, 2:32:05 PM)

60.05

+0.1 (+0.17%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)04-30 2025-04-30

Earnings (Next)07-11 2025-07-11

Inst Owners8.28%

Inst Owner ChangeN/A

Ins Owners3.18%

Ins Owner ChangeN/A

Market Cap5.27B

Analysts82.22

Price Target71.4 (18.9%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend42.89

Dividend Growth(5Y)N/A

DP197.36%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-9.68%

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-30.77%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-5.83%

Valuation

		Industry Rank	Sector Rank
PE	2.76
Fwd PE	23.32
P/S	2.59
P/FCF	N/A
P/OCF	186.27
P/B	3.06
P/tB	11.1
EV/EBITDA	20.91

EPS(TTM)21.78

EY36.27%

EPS(NY)2.57

Fwd EY4.29%

FCF(TTM)-2.08

FCFYN/A

OCF(TTM)0.32

OCFY0.54%

SpS23.18

BVpS19.64

TBVpS5.41

PEG (NY)0.03

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	48.54%
ROE	110.84%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	93.94%
GM	34.97%
FCFM	N/A

ROA(3y)15.56%

ROA(5y)8.97%

ROE(3y)34.62%

ROE(5y)20.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.1%

GM growth 5Y-2.15%

F-Score7

Asset Turnover0.52

Health

		Industry Rank	Sector Rank
Debt/Equity	0.89
Debt/FCF	N/A
Debt/EBITDA	4.66
Cap/Depr	60.06%
Cap/Sales	10.38%
Interest Coverage	N/A
Cash Conversion	8.64%
Profit Quality	N/A
Current Ratio	3.47
Quick Ratio	1.81
Altman-Z	N/A

F-Score7

WACC8.56%

ROIC/WACCN/A

Cap/Depr(3y)77.43%

Cap/Depr(5y)88.04%

Cap/Sales(3y)14.31%

Cap/Sales(5y)16.42%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)5151.99%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%83.2%

EPS Next Y80%

EPS Next 2Y123.61%

EPS Next 3Y108.01%

EPS Next 5YN/A

Revenue 1Y (TTM)-41.57%

Revenue growth 3Y-8.77%

Revenue growth 5Y-4.17%

Sales Q2Q%-35.12%

Revenue Next Year-13.85%

Revenue Next 2Y-1.34%

Revenue Next 3Y3.16%

Revenue Next 5Y20.59%

EBIT growth 1Y-126.37%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year177.08%

EBIT Next 3Y69.2%

EBIT Next 5YN/A

FCF growth 1Y47.84%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-77.42%

OCF growth 3Y155.79%

OCF growth 5Y-0.17%

AKER BIOMARINE ASA (AKBM.OL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens